Cargando…

Association of Clinical Outcomes With Sex in Patients Receiving Chronic Maintenance Antiplatelet Monotherapy After Percutaneous Coronary Intervention: A Post Hoc Gender Analysis of the HOST‐EXAM Study

BACKGROUND: Clopidogrel monotherapy was more effective in reducing the risk of adverse clinical events than aspirin monotherapy in patients who underwent percutaneous coronary intervention (PCI) with drug‐eluting stent (DES), according to the HOST‐EXAM (Harmonizing Optimal Strategy for Treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Eun‐Seok, Jun, Eun Jung, Kim, Bitna, Won, Ki‐Bum, Koo, Bon‐Kwon, Kang, Jeehoon, Park, Kyung Woo, Rhee, Tae‐Min, Yang, Han‐Mo, Han, Jung‐Kyu, Kim, Hyo‐Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227252/ https://www.ncbi.nlm.nih.gov/pubmed/37042284 http://dx.doi.org/10.1161/JAHA.122.026770

Ejemplares similares

Cost-Effectiveness of Clopidogrel vs Aspirin Monotherapy After Percutaneous Coronary Intervention: Results From the HOST-EXAM Study
por: Hwang, Doyeon, et al.
Publicado: (2023)

Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI
por: Ki, You-Jeong, et al.
Publicado: (2021)

The Evolving Concept of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: Focus on Unique Feature of East Asian and “Asian Paradox”
por: Kang, Jeehoon, et al.
Publicado: (2018)

Efficacy and Safety of Long-Term and Short-Term Dual Antiplatelet Therapy: A Meta-Analysis of Comparison between Asians and Non-Asians
por: Ki, You-Jeong, et al.
Publicado: (2020)

Association Between Low Muscle Mass and Prognosis of Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Kim, Chi‐Hoon, et al.
Publicado: (2020)

Erratum: Correction of Text in the Article “Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI”
por: Ki, You-Jeong, et al.
Publicado: (2022)

Sex-Based Outcomes of P2Y12 Inhibitor Monotherapy After Three Months of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention
por: Shin, Eun-Seok, et al.
Publicado: (2023)

SYNTAX Score and SYNTAX Score II Can Predict the Clinical Outcomes of Patients with Left Main and/or 3-Vessel Disease Undergoing Percutaneous Coronary Intervention in the Contemporary Cobalt-Chromium Everolimus-Eluting Stent Era
por: Kang, Jeehoon, et al.
Publicado: (2019)

Impact of Intensive Glucose Control in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: 3-Year Clinical Outcomes
por: Park, Jiesuck, et al.
Publicado: (2020)

Antiplatelet strategy during ad-hoc percutaneous coronary intervention in elective patients: how aggressive should we be?
por: Selvarajah, Abi, et al.
Publicado: (2023)

The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era
por: Zheng, Chengbin, et al.
Publicado: (2019)

Complete Revascularization of Multivessel Coronary Artery Disease Does Not Improve Clinical Outcome in ST-Segment Elevation Myocardial Infarction Patients with Reduced Left Ventricular Ejection Fraction
por: Kang, Jeehoon, et al.
Publicado: (2020)

The stent in the high-bleeding risk patient: antiplatelet monotherapy?
por: Capranzano, Piera
Publicado: (2022)

Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
por: Park, Jiesuck, et al.
Publicado: (2022)

Vascular Remodeling After Drug-Coated Balloon Treatment: Insight From Optical Coherence Tomography
por: Shin, Eun-Seok, et al.
Publicado: (2023)

Association of Side-Branch Treatment and Patient Factors in Left Anterior Descending Artery True Bifurcation Lesions: Analysis from the GRAND-DES Pooled Registry
por: Oh, Gyu Chul, et al.
Publicado: (2020)

The natural course of nonculprit coronary artery lesions; analysis by serial quantitative coronary angiography
por: Kang, Jeehoon, et al.
Publicado: (2018)

The Clinical Impact of β-Blocker Therapy on Patients With Chronic Coronary Artery Disease After Percutaneous Coronary Intervention
por: Park, Jiesuck, et al.
Publicado: (2022)

Safety and Efficacy of Second-Generation Drug-Eluting Stents in Real-World Practice: Insights from the Multicenter Grand-DES Registry
por: Ki, You-Jeong, et al.
Publicado: (2020)

Aspirin Monotherapy beyond 12 Months of Dual Antiplatelet Therapy in Patients with Acute Myocardial Infarction: Oldies But Goodies?
por: Suh, Jung-Won
Publicado: (2019)

Impact of the Dual Antiplatelet Therapy Score on Clinical Outcomes in Acute Coronary Syndrome Patients Receiving P2Y12 Inhibitor Monotherapy
por: Huang, Sheng-Wei, et al.
Publicado: (2022)

Percutaneous native kidney biopsy in patients receiving antiplatelet agents- is it necessary to stop them routinely?
por: Nayak-Rao, S.
Publicado: (2015)

Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort
por: Obayashi, Yuki, et al.
Publicado: (2022)

Real-world evidence of switching P2Y12 receptor–inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry
por: Kang, Jeehoon, et al.
Publicado: (2023)

Comparative Efficacy and Safety of P2Y12 Inhibitor Monotherapy and Dual Antiplatelet Therapy in Patients with and without Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
por: Feng, Wen-Han, et al.
Publicado: (2022)

The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease
por: Kim, Hyun Jung, et al.
Publicado: (2017)

Angiographic complete revascularization versus incomplete revascularization in patients with diabetes mellitus
por: Hwang, Doyeon, et al.
Publicado: (2022)

P2Y(12) inhibitor monotherapy in complex percutaneous coronary intervention: A post-hoc analysis of SMART-CHOICE randomized clinical trial
por: Roh, Ji Woong, et al.
Publicado: (2021)

Shortened dual antiplatelet therapy in contemporary percutaneous coronary intervention era
por: Han, Jennie, et al.
Publicado: (2021)

Antiplatelet Therapy and Percutaneous Coronary Interventions
por: Davanzo, Rene Hameau, et al.
Publicado: (2021)

P2Y12 Inhibitor Monotherapy versus Conventional Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Meta-Analysis
por: Feng, Wen-Han, et al.
Publicado: (2023)

Sarcopenia Index as a Predictor of Clinical Outcomes in Older Patients with Coronary Artery Disease
por: Lee, Hak Seung, et al.
Publicado: (2020)

Optimal Oversizing Index Depending on Valve Type and Leakage-Proof Function for Preventing Paravalvular Leakage after Transcatheter Aortic Valve Implantation
por: Ki, You-Jeong, et al.
Publicado: (2020)

Anticoagulation and Antiplatelet Agent Resumption Timing following Traumatic Brain Injury
por: Jung, In-Ho, et al.
Publicado: (2023)

The Effect of Preoperative Antiplatelet Therapy on Hemorrhagic Complications after Decompressive Craniectomy in Patients with Traumatic Brain Injury
por: Han, Hokyun, et al.
Publicado: (2016)

Long-term Outcomes of Clopidogrel Monotherapy versus Prolonged Dual Antiplatelet Therapy beyond 12 Months after Percutaneous Coronary Intervention in High-risk Patients
por: Kim, Dong-Yeon, et al.
Publicado: (2021)

Antitcoagulant and antiplatelet activities of scolymoside
por: Yoon, Eun-Kyung, et al.
Publicado: (2015)

Ticagrelor Monotherapy After 3-Month Dual Antiplatelet Therapy in Acute Coronary Syndrome by High Bleeding Risk: The Subanalysis From the TICO Trial
por: Lee, Yong-Joon, et al.
Publicado: (2021)

Recurrent Non-Variceal Upper Gastrointestinal Bleeding among Patients Receiving Dual Antiplatelet Therapy
por: Yoo, Ah Young, et al.
Publicado: (2023)

Intensity of antiplatelet therapy and percutaneous coronary intervention
por: Aronow, Wilbert S
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_r0mqetij7d664hhk4e9ne5ohvv